Animal research has particularly focused on diet-induced obesity, type 2 diabetes rodent models, and non-alcoholic steatohepatitis (NASH) models
1a), heterozygotes appeared unremarkable, with normal body weights, liver weights, blood glucose and blood lactate (Fig
The most common side effects are minor bruising at the IV site and a brief vitamin taste during the infusion
This medication is best for people with obesity and overweight who want to reduce body weight, control blood sugar in patients with type 2 diabetes, and manage weight-related complications such as moderate to severe obstructive sleep apnea
Farxiga's role in non-diabetic weight management remains complementary rather than primary
Clinical trials excluded participants who were already taking other weight management drugs